Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio Path Holdings Inc (NASDAQ:BPTH)

1.96
Delayed Data
As of 4:00pm ET
 -0.03 / -1.51%
Today’s Change
1.00
Today|||52-Week Range
3.19
+56.80%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$178.6M

Company Description

Bio-Path Holdings, Inc. is a clinical stage biotechnology company, which focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology designed to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous infusion. The company has drug delivery platform technology with composition of matter intellectual property for systemic delivery of antisense. Bio-Path Holdings was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Maria Tari in May 2007 and is headquartered in Bellaire, TX.

Contact Information

Bio-Path Holdings, Inc.
4710 Bellaire Boulevard
Bellaire Texas 77054
P:(832) 742-1357
Investor Relations:

Employees

Shareholders

Other institutional9.81%
Mutual fund holders2.78%
Individual stakeholders17.61%

Top Executives

Peter H. NielsenChairman, President, CEO, CFO, Treasurer & CAO
Ulrich W. MuellerChief Operating Officer & Secretary
Ana Maria TariDirector-Preclinical Operations & Research
Tara SadeghiDirector-Clinical Operations